Online citations, reference lists, and bibliographies.
← Back to Search

Biological Functions Of Hyaluronan And Cytokine-inducible Deubiquitinating Enzymes.

S. Ramakrishna, B. Suresh, Kwang-Hyun Baek
Published 2015 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
The modification of proteins through post-translation and degradation by the ubiquitin-proteasome system plays a pivotal role in a broad array of biological processes. Reversal of this process by deubiquitination is a central step in the maintenance and regulation of cellular homeostasis. It now appears that the regulation of ubiquitin pathways by deubiquitinating enzymes (DUBs) could be used as targets for anticancer therapy. Recent success in inducing apoptosis in cancerous cells by USP17, a cytokine-inducible DUB encoding two hyaluronan binding motifs (HABMs) showing direct interaction with hyaluronan (HA), could prove a promising step in the development of DUBs containing HABMs as agents in anticancer therapeutics. In this review, we summarize the importance of hyaluronan (HA) in cancer, the role played by DUBs in apoptosis, and a possible relationship between DUBs and HA in cancerous cells, suggesting new strategies for applying DUB enzymes as potential anticancer therapeutics.
This paper references
10.1074/jbc.R100039200
Hyaluronan-Cell Interactions in Cancer and Vascular Disease*
B. Toole (2002)
10.1021/BM000283N
A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells.
Y. Luo (2000)
10.1016/j.immuni.2010.07.002
K33-linked polyubiquitination of T cell receptor-zeta regulates proteolysis-independent T cell signaling.
H. Huang (2010)
10.3109/10409238.2011.620943
Cellular strategies for making monoubiquitin signals
Harish N Ramanathan (2012)
10.1074/JBC.M308168200
Elevated Hyaluronan Production Induces Mesenchymal and Transformed Properties in Epithelial Cells*
A. Zoltan-Jones (2003)
10.1016/S0945-053X(01)00186-X
CD44-mediated uptake and degradation of hyaluronan.
W. Knudson (2002)
10.1615/CRITREVONCOG.V5.I2-3.50
The CD44 adhesion molecule and metastasis.
K. Tanabe (1994)
10.1074/jbc.R100036200
Hyaluronan-binding Proteins: Tying Up the Giant*
A. J. Day (2002)
10.1083/JCB.124.1.71
Expression and modulation of CD44 variant isoforms in humans
C. Mackay (1994)
10.1016/J.BBAMCR.2004.10.003
Mechanism and function of deubiquitinating enzymes.
A. Y. Amerik (2004)
10.1016/j.cell.2006.06.039
A Role for the Deubiquitinating Enzyme USP28 in Control of the DNA-Damage Response
D. Zhang (2006)
10.1074/JBC.272.14.8957
Molecular Cloning and Characterization of a cDNA Encoding the Third Putative Mammalian Hyaluronan Synthase*
A. Spicer (1997)
Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer.
K. Ropponen (1998)
10.1074/jbc.R700036200
Hyaluronan Synthases: A Decade-plus of Novel Glycosyltransferases*
P. Weigel (2007)
10.1021/bc8000485
Hyaluronic acid-paclitaxel conjugate micelles: synthesis, characterization, and antitumor activity.
H. Lee (2008)
PGP9.5 as a marker for invasive colorectal cancer.
T. Yamazaki (2002)
10.1083/JCB.108.5.1899
Immunoelectron microscopic localization of hyaluronic acid-binding region and link protein epitopes in brain
J. A. Ripellino (1989)
10.1016/0959-8049(95)00420-3
Splice variants of the cell surface glycoprotein CD44 associated with metastatic tumour cells are expressed in normal tissues of humans and cynomolgus monkeys.
K. H. Heider (1995)
10.1042/BST0370937
The emerging complexity of protein ubiquitination.
D. Komander (2009)
10.1038/ncb1384
Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activation
C. Wu (2006)
10.1182/BLOOD-2004-10-3825
Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myeloma.
Sophia Adamia (2005)
10.1074/jbc.273.44.28878
Hyaluronan Bound to CD44 on Keratinocytes Is Displaced by Hyaluronan Decasaccharides and Not Hexasaccharides*
R. Tammi (1998)
10.1083/JCB.118.4.971
CD44H regulates tumor cell migration on hyaluronate-coated substrate
L. Thomas (1992)
10.2353/AJPATH.2006.060032
Concurrent expression of hyaluronan biosynthetic and processing enzymes promotes growth and vascularization of prostate tumors in mice.
M. Simpson (2006)
10.1002/(SICI)1097-0142(19991115)86:10<2000::AID-CNCR17>3.0.CO;2-N
Hyaluronan in serum as an indicator of progressive disease in hyaluronan‐producing malignant mesothelioma
A. Thylén (1999)
10.1007/s12013-011-9185-5
The Multifaceted Roles of USP7: New Therapeutic Opportunities
B. F. Nicholson (2011)
10.1016/J.CEB.2004.02.005
The novel functions of ubiquitination in signaling.
L. Sun (2004)
10.4161/cc.8.11.8739
DUBs and cancer: The role of deubiquitinating enzymes as oncogenes, non-oncogenes and tumor suppressors
Sajjad Hussain (2009)
10.2174/138920108785161514
The development of hyaluronan as a drug transporter and excipient for chemotherapeutic drugs.
T. Brown (2008)
10.1146/annurev.biochem.78.082307.091526
Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes.
Francisca E. Reyes-Turcu (2009)
10.1016/j.cytogfr.2013.05.007
Molecular mechanisms and functions of cytokine-inducible deubiquitinating enzymes.
Key-Hwan Lim (2013)
10.1111/j.1742-4658.2011.08069.x
Hyaluronan matrices in pathobiological processes
A. Wang (2011)
10.1016/J.YGENO.2004.11.013
The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.
J. Burrows (2005)
10.1074/jbc.M700915200
Hyaluronan Export by the ABC Transporter MRP5 and Its Modulation by Intracellular cGMP*
T. Schulz (2007)
10.1002/1097-0142(19890701)64:1<68::AID-CNCR2820640112>3.0.CO;2-I
A longitudinal study of the hyaluronan level in the serum of patients with malignant mesothelioma under treatment. Hyaluronan as an indicator of progressive disease
Inger Marie S. Dahl (1989)
10.1186/1471-2164-7-292
Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability
Ju-Mi Shin (2006)
10.1038/sj.emboj.7601567
The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2
L. F. Stevenson (2007)
Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody.
Y. Guo (1994)
10.1016/j.cell.2006.03.041
Cyld Inhibits Tumor Cell Proliferation by Blocking Bcl-3-Dependent NF-κB Signaling
R. Massoumi (2006)
10.1177/43.7.7608523
Association of hyaluronan with rat vascular endothelial and smooth muscle cells.
P. Eggli (1995)
10.1074/jbc.M007601200
Epidermal Growth Factor Activates Hyaluronan Synthase 2 in Epidermal Keratinocytes and Increases Pericellular and Intracellular Hyaluronan*
Juha-Pekka Pienimäki (2001)
10.4161/auto.9041
Hyperglycemia, intracellular hyaluronan synthesis, cyclin D3 and autophagy
A. Wang (2009)
10.1002/j.1460-2075.1994.tb06261.x
Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein.
B. Yang (1994)
10.1093/emboj/17.24.7151
The ubiquitin–proteasome pathway: on protein death and cell life
A. Ciechanover (1998)
10.1002/dvdy.20328
Three vertebrate hyaluronan synthases are expressed during mouse development in distinct spatial and temporal patterns
Janet Y L Tien (2005)
10.1093/GLYCOB/12.3.37R
Hyaluronan promotes the malignant phenotype.
B. Toole (2002)
10.1016/S0065-2776(08)60537-4
CD44 and its interaction with extracellular matrix.
J. Lesley (1993)
10.1038/nrm1004
CD44: From adhesion molecules to signalling regulators
H. Ponta (2003)
10.1007/978-3-540-69494-6_6
Signaling through monoubiquitination.
S. Sigismund (2004)
10.1084/JEM.176.2.623
Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein
M. Sy (1992)
10.1073/PNAS.93.15.7832
Expression of hyaluronidase by tumor cells induces angiogenesis in vivo.
D. Liu (1996)
10.1038/sj.embor.7400822
Itch/AIP4 mediates Deltex degradation through the formation of K29‐linked polyubiquitin chains
P. Chastagner (2006)
10.1074/JBC.271.38.23400
Molecular Cloning and Characterization of a Putative Mouse Hyaluronan Synthase*
A. Spicer (1996)
10.1016/0092-8674(91)90403-L
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
U. Guenthert (1991)
10.1002/IJC.2910500414
Differential expression of the CD44 molecule in human brain tumours
M. Kuppner (1992)
10.1128/MCB.15.3.1265
A ubiquitin mutant with specific defects in DNA repair and multiubiquitination.
J. Spence (1995)
10.1158/0008-5472.CAN-08-0365
BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization.
Karen H. Ventii (2008)
Molecular cloning, identification, and sequence of the hyaluronan synthase gene from group A Streptococcus pyogenes.
P. Deangelis (1993)
10.1038/nature01811
Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB
T. Brummelkamp (2003)
The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells.
V. Assmann (1998)
10.1084/JEM.182.2.419
Glycosylation of CD44 negatively regulates its recognition of hyaluronan
S. Katoh (1995)
10.1084/JEM.186.12.1985
Induction of Apoptosis of Metastatic Mammary Carcinoma Cells In Vivo by Disruption of Tumor Cell Surface CD44 Function
Q. Yu (1997)
10.1021/mp800024g
Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor.
Virginia M Platt (2008)
10.1002/iub.589
Protein monoubiquitination and polyubiquitination generate structural diversity to control distinct biological processes
Martin C. Sadowski (2012)
Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.
R. E. Eliaz (2001)
10.1073/PNAS.93.8.3275
DUB-1, a deubiquitinating enzyme with growth-suppressing activity.
Y. Zhu (1996)
10.1038/sj.onc.1201861
BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression
D. Jensen (1998)
10.1126/SCIENCE.1127085
Proteasome-Independent Functions of Ubiquitin in Endocytosis and Signaling
D. Mukhopadhyay (2007)
10.1074/JBC.M311291200
DUB-3, a Cytokine-inducible Deubiquitinating Enzyme That Blocks Proliferation*
J. Burrows (2004)
10.2217/14796694.3.2.191
Deubiquitinating enzymes as novel anticancer targets.
B. Nicholson (2007)
10.1016/S0002-9440(10)65086-9
Perturbation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites.
R. M. Peterson (2000)
10.1158/0008-5472.CAN-05-1022
HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor.
V. Lokeshwar (2005)
10.1111/j.1349-7006.2004.tb03179.x
Mechanism and biological significance of CD44 cleavage
O. Nagano (2004)
10.1002/IJC.2910440311
Sera of children with renal tumours contain low‐molecular‐mass hyaluronic acid
S. Kumar (1989)
10.1128/MCB.14.12.7876
Stress resistance in Saccharomyces cerevisiae is strongly correlated with assembly of a novel type of multiubiquitin chain.
T. Arnason (1994)
10.1074/jbc.M110.162321
Lys-63-specific Deubiquitination of SDS3 by USP17 Regulates HDAC Activity*
S. Ramakrishna (2011)
10.1002/ijc.10683
Expression of hyaluronan synthase 2 or hyaluronidase 1 differentially affect the growth rate of transplantable colon carcinoma cell tumors
A. Jacobson (2002)
10.2741/3108
Hyaluronan and hyaluronidase in genitourinary tumors.
M. Simpson (2008)
10.1074/JBC.M202404200
Hyaluronan Oligosaccharides Inhibit Anchorage-independent Growth of Tumor Cells by Suppressing the Phosphoinositide 3-Kinase/Akt Cell Survival Pathway*
S. Ghatak (2002)
10.1017/S1462399411002031
Pharmacological targets in the ubiquitin system offer new ways of treating cancer, neurodegenerative disorders and infectious diseases
M. Edelmann (2011)
Purification, partial characterization of rat kidney hyaluronic acid binding protein and its localization on the cell surface.
S. Gupta (1991)
10.2174/138920306776359740
Cytokine-regulated protein degradation by the ubiquitination system.
Kwang-Hyun Baek (2006)
10.1074/jbc.M806430200
Cyclin D3 Mediates Synthesis of a Hyaluronan Matrix That Is Adhesive for Monocytes in Mesangial Cells Stimulated to Divide in Hyperglycemic Medium*
J. Ren (2009)
10.1023/A:1015170907274
Targeted Delivery of Doxorubicin by HPMA Copolymer-Hyaluronan Bioconjugates
Yi Luo (2004)
A peptide with three hyaluronan binding motifs inhibits tumor growth and induces apoptosis.
Xue-Ming Xu (2003)
10.1158/1078-0432.CCR-07-1228
Targeting Hyaluronan Interactions in Malignant Gliomas and Their Drug-Resistant Multipotent Progenitors
A. G. Gilg (2008)
10.1016/S0002-9440(10)64757-8
Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival.
P. Auvinen (2000)
10.1074/jbc.R100038200
Signaling Properties of Hyaluronan Receptors*
E. Turley (2002)
10.1021/BC9900338
Synthesis and selective cytotoxicity of a hyaluronic acid-antitumor bioconjugate.
Y. Luo (1999)
10.1042/BJ20080067
Control of AMPK-related kinases by USP9X and atypical Lys(29)/Lys(33)-linked polyubiquitin chains.
Abdallah K Al-Hakim (2008)
10.1074/JBC.C300173200
Regulation of Multidrug Resistance in Cancer Cells by Hyaluronan*
S. Misra (2003)
10.2174/138920108785161569
Hyaluronan oligosaccharides as a potential anticancer therapeutic.
B. Toole (2008)
Glycosaminoglycan production by murine melanoma variants in vivo and in vitro.
E. Turley (1985)
10.1084/JEM.174.4.859
Distinct effects of two CD44 isoforms on tumor growth in vivo
M. Sy (1991)
10.1158/0008-5472.CAN-09-4152
The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.
C. McFarlane (2010)
10.1016/S0945-053X(01)00172-X
The six hyaluronidase-like genes in the human and mouse genomes.
A. B. Csóka (2001)
10.1016/S0022-5347(05)68050-0
Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade.
V. Lokeshwar (2000)
10.1074/jbc.273.18.11342
The Hyaluronan Receptor RHAMM Regulates Extracellular-regulated Kinase*
S. Zhang (1998)
10.1016/J.YEXCR.2005.03.026
Antisense inhibition of hyaluronan synthase-2 in human osteosarcoma cells inhibits hyaluronan retention and tumorigenicity.
Y. Nishida (2005)
10.1074/JBC.271.17.9875
Expression Cloning and Molecular Characterization of HAS Protein, a Eukaryotic Hyaluronan Synthase (*)
N. Itano (1996)
10.1016/j.chembiol.2012.02.007
Discovery of specific inhibitors of human USP7/HAUSP deubiquitinating enzyme.
C. Reverdy (2012)
10.1016/S1535-6108(04)00055-8
The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer.
E. Graner (2004)
10.1369/jhc.4A6356.2004
Intracellular Hyaluronan in Arterial Smooth Muscle Cells: Association with Microtubules, RHAMM, and the Mitotic Spindle
S. Evanko (2004)
10.1016/j.chembiol.2012.04.001
Selective Inhibition of USP7
R. Ménard (2012)
The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior.
W. Rudy (1993)
10.1074/JBC.270.27.16198
A Novel Glycosaminoglycan-binding Protein Is the Vertebrate Homologue of the Cell Cycle Control Protein, Cdc37 (*)
N. Grammatikakis (1995)
10.1182/BLOOD.V98.6.1935
The deubiquitinating enzyme DUB-2 prolongs cytokine-induced signal transducers and activators of transcription activation and suppresses apoptosis following cytokine withdrawal.
T. Migone (2001)
Lymph node (but not spleen) invasion by murine lymphoma is both CD44- and hyaluronate-dependent.
M. Zahalka (1995)
10.1016/S1097-2765(04)00157-1
A dynamic role of HAUSP in the p53-Mdm2 pathway.
M. Li (2004)
10.1074/jbc.M304774200
DUB-1A, a Novel Deubiquitinating Enzyme Subfamily Member, Is Polyubiquitinated and Cytokine-inducible in B-lymphocytes*
Kwang-Hyun Baek (2004)
10.1074/JBC.M103481200
Hyaluronan Enters Keratinocytes by a Novel Endocytic Route for Catabolism*
R. Tammi (2001)
10.1084/JEM.149.2.507
Hyaluronidase-sensitive halos around adherent cells. Their role in blocking lymphocyte-mediated cytolysis
W. McBride (1979)
10.1074/JBC.M002527200
Hyaluronan binding by cell surface CD44.
J. Lesley (2000)
Overproduction of hyaluronan by expression of the hyaluronan synthase Has2 enhances anchorage-independent growth and tumorigenicity.
R. Kosaki (1999)
10.1159/000084510
Hyaluronan: A Critical Component of Epithelial-Mesenchymal and Epithelial-Carcinoma Transitions
B. Toole (2005)
Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression.
V. J. Wielenga (1993)
10.1083/JCB.106.3.845
Light and electron microscopic studies on the localization of hyaluronic acid in developing rat cerebellum
J. A. Ripellino (1988)
10.1371/journal.pone.0037772
Hyaluronan Binding Motifs of USP17 and SDS3 Exhibit Anti-Tumor Activity
S. Ramakrishna (2012)
10.1038/sj.emboj.7601061
Molecular determinants of polyubiquitin linkage selection by an HECT ubiquitin ligase
M. Wang (2006)
10.1056/NEJM199312233292615
CD44--a new prognostic marker for neuroblastoma.
M. Favrot (1993)
10.1006/EXCR.1999.4645
Expression of recombinant hyaluronan synthase (HAS) isoforms in CHO cells reduces cell migration and cell surface CD44.
J. Brinck (1999)
10.1002/JCP.1041620115
New CD44 splice variants associated with human breast cancers
N. Iida (1995)
10.1016/S0046-8177(88)80168-0
Tumor invasion: a consequence of destructive and compositional matrix alterations.
B. Pauli (1988)
10.1182/BLOOD.V98.3.636
DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.
K. H. Baek (2001)
High levels of stromal hyaluronan predict poor disease outcome in epithelial ovarian cancer.
M. Anttila (2000)
10.1016/J.BBAGEN.2004.02.013
Intracellular hyaluronan: a new frontier for inflammation?
Vincent C. Hascall (2004)
10.1016/0006-291X(82)92101-5
Purification of a hyaluronate-binding protein fraction that modifies cell social behavior.
E. Turley (1982)
Molecular characterization of hasA from an operon required for hyaluronic acid synthesis in group A streptococci.
B. Dougherty (1994)
10.1074/jbc.273.35.22466
HYAL2, a Human Gene Expressed in Many Cells, Encodes a Lysosomal Hyaluronidase with a Novel Type of Specificity*
G. Lepperdinger (1998)
10.1073/PNAS.89.24.12160
Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.
G. Screaton (1992)
10.1074/JBC.M410882200
Hyaluronan Constitutively Regulates ErbB2 Phosphorylation and Signaling Complex Formation in Carcinoma Cells*
S. Ghatak (2005)
10.1002/ijc.27707
Increased hyaluronan content and stromal cell CD44 associate with HER2 positivity and poor prognosis in human breast cancer
P. Auvinen (2013)
Effects of detergent solubilization on the hyaluronate-binding protein from membranes of simian virus 40-transformed 3T3 cells.
C. Underhill (1983)
10.1016/j.semcancer.2008.03.017
Hyaluronidases in cancer biology.
R. Stern (2008)
10.3892/IJO.27.1.97
Expression and functional analyses of mHAUSP regulating apoptosis of cervical adenocarcinoma cells.
Kyong-Jai Yoo (2005)
10.1016/0304-4165(83)90242-8
Macromolecular basis of globular protein exclusion and of swelling pressure in loose connective tissue (umbilical cord).
F. A. Meyer (1983)
10.1074/JBC.272.1.51
DUB-2 Is a Member of a Novel Family of Cytokine-inducible Deubiquitinating Enzymes*
Y. Zhu (1997)
10.1002/(SICI)1097-0215(19990505)81:3<411::AID-IJC15>3.0.CO;2-F
Hyaluronic acid as drug delivery for sodium butyrate: Improvement of the anti‐proliferative activity on a breast‐cancer cell line
D. Coradini (1999)
10.1038/nsmb.2142
Bilateral inhibition of HAUSP deubiquitinase by a viral interferon regulatory factor protein
H. Lee (2011)
10.1074/JBC.271.38.23395
Functional Cloning of the cDNA for a Human Hyaluronan Synthase*
A. Shyjan (1996)
10.3109/07853899609033126
Serum hyaluronan as a disease marker.
T. Laurent (1996)
10.1074/jbc.M002737200
Molecular Characterization of a Novel Intracellular Hyaluronan-binding Protein*
L. Huang (2000)
10.1084/JEM.180.1.53
Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development
A. Bartolazzi (1994)
10.1073/PNAS.76.12.6299
Hyaluronate and invasiveness of the rabbit V2 carcinoma.
B. Toole (1979)
10.1172/JCI10272
Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme.
T. Camenisch (2000)
10.1073/PNAS.0308411100
Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells.
H. Ovaa (2004)
10.1007/s00018-010-0504-6
The role of deubiquitinating enzymes in apoptosis
S. Ramakrishna (2010)
10.1074/JBC.271.38.22945
Molecular Identification of a Putative Human Hyaluronan Synthase*
K. Watanabe (1996)
10.1177/002215549904701013
Intracellular Localization of Hyaluronan in Proliferating Cells
S. Evanko (1999)
10.1054/bjoc.2001.1922
Hyaluronan production increases the malignant properties of mesothelioma cells
Y. Li (2001)
10.1016/S0092-8674(00)80574-7
A Novel Ubiquitination Factor, E4, Is Involved in Multiubiquitin Chain Assembly
M. Koegl (1999)
10.1016/j.semcancer.2008.03.009
Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells.
B. Toole (2008)
Hyaluronan stimulates tumor cell migration by modulating the fibrin fiber architecture.
W. Hayen (1999)
Isolation of a Streptococcus pyogenes gene locus that directs hyaluronan biosynthesis in acapsular mutants and in heterologous bacteria.
P. Deangelis (1993)
10.1016/J.EJCA.2003.11.016
PGP9.5 mRNA could contribute to the molecular-based diagnosis of medullary thyroid carcinoma.
T. Takano (2004)
10.1089/hyb.2010.0005
Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.
S. Ramakrishna (2010)



This paper is referenced by
10.1016/j.bbcan.2017.10.004
Deubiquitylating enzymes as cancer stem cell therapeutics.
S. Haq (2018)
10.1007/s00018-015-2129-2
Decision for cell fate: deubiquitinating enzymes in cell cycle checkpoint
Key-Hwan Lim (2015)
10.1080/00914037.2018.1446138
Recombinant human bone morphogenetic protein-2 loaded porous β-tricalcium phosphate microsphere-hyaluronic acid composites promoted osseointegration around titanium implants
J. Lee (2019)
Testování povrchové aktivity hyaluronanu sodného
Tereza Dehnerová (2018)
10.1186/s40824-020-0183-9
The efficacy of rhBMP-2 loaded hydrogel composite on bone formation around dental implants in mandible bone defects of minipigs
Hao-Zhen Lyu (2020)
10.1038/s41392-018-0012-y
Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases
S. Bhattacharya (2018)
10.1016/j.semcancer.2019.07.002
Intracellular hyaluronan: Importance for cellular functions.
S. Skandalis (2019)
10.1016/j.pharmthera.2016.12.003
The bad seed gardener: Deubiquitinases in the cancer stem‐cell signaling network and therapeutic resistance
Guan-Zhong Qiu (2017)
10.1038/cdd.2016.53
Regulation of pluripotency and differentiation by deubiquitinating enzymes
B. Suresh (2016)
10.1007/s00018-015-2030-z
The role of deubiquitinating enzymes in spermatogenesis
B. Suresh (2015)
10.15406/jsrt.2017.02.00083
Future application of deubiquitylating enzymes for rapid and efficient cellular reprogramming
Saba Haq (2017)
10.1155/2016/6705927
The Importance of Ubiquitination and Deubiquitination in Cellular Reprogramming
B. Suresh (2016)
10.1038/oncsis.2017.45
The deubiquitinating enzymes USP4 and USP17 target hyaluronan synthase 2 and differentially affect its function
M. Mehic (2017)
10.1038/s41388-018-0411-0
USP17 mediates macrophage-promoted inflammation and stemness in lung cancer cells by regulating TRAF2/TRAF3 complex formation
C. Lu (2018)
10.1016/j.abb.2016.10.008
Steady-state kinetic studies reveal that the anti-cancer target Ubiquitin-Specific Protease 17 (USP17) is a highly efficient deubiquitinating enzyme.
Nicole M Hjortland (2016)
10.4137/BCBCR.S40075
A Multifaceted Role for Myd88-Dependent Signaling in Progression of Murine Mammary Carcinoma
M. J. Higgins (2016)
Semantic Scholar Logo Some data provided by SemanticScholar